Biochip Market to Witness a 12.52% CAGR By 2026
Growing
prevalence of chronic as well as infectious disease and increasing demand for personalized
medicine are some major factors propelling the growth of the global biochip market.
According to TechSci Research report, “Global Biochip
Market By Technology (Microarray v/s Microfluidics), By Type (DNA Chips,
Lab-On-a-Chips, Protein Chips, Others), By Application (Drug Discovery &
Development, Disease Diagnostics, Genomics, Proteomics, Others), By End User
(Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics
Centers, Academic & Research Institutes, Others), By Company, By Region,
Forecast & Opportunities, 2026”,
the biochip market was valued at USD11694.24 million in
2020 and is expected to reach USD23890.58 million by registering a CAGR of
12.52%. The increasing prevalence of various chronic diseases like cancer,
immunological disorders and other infectious diseases, especially among the geriatric
population is acting as a major growth factor for the global biochip market.
Moreover, the rising demand for targeted therapies and personalized medicines,
extensive R&D activities and supportive government policies are some other
key factors supporting the global biochip market growth. Furthermore, ongoing
technological innovations and new product launches by major players operating
in the market are expected to create lucrative growth opportunities for the market
over the next five years. Additionally, biochips are also finding applications in
the field of genomics, genotyping and proteomics. This in turn is likely to
positively influence the market growth through 2026. Apart from that, various
economies are increasing spending on clinical research which is further
augmenting the growth of the global biochip market. However, the high cost of
biochips and lack of awareness especially in developing and underdeveloped
countries can hamper the market growth.
Browse 132 Figures spread
through 110 Pages and an in-depth TOC
on "Global Biochip Market"
https://www.techsciresearch.com/report/global-biochip-market/1259.html
The global biochip market is segmented based on type,
technology, application, end user and region. Based on end user, the market can
be fragmented into biotechnology & pharmaceutical companies, hospitals
& diagnostics centers, academic & research institutes, and others. The
hospitals & diagnostic centers segment dominated the market in 2020 by
holding 40.53% of the market share and is expected to maintain its leading
position in the market on account of the extensive use of biochips by them.
This can be ascribed to the associated advantages of biochips such as affordability,
time saving and ability to deliver high throughput without requiring
instruments. In terms of application, the market is fragmented into drug
discovery & development, disease diagnostics, genomics, proteomics, others.
Out of which, the drug discovery & development application segment held the
largest market share in 2020 on account of the growing development of targeted
and personalized medicines for treating cancer. Also, the disease diagnostics
segment is projected to witness the highest growth in the forthcoming years due
to the rising demand for the detection and diagnosis of genetic disorders across
the globe. Based
on type, the market can be categorized into DNA Chips, Lab-On-a-Chips and Protein Chips. Out of which, the DNA chips segment dominated the market in
2020 on account of its widespread adoption and use of DNA chip products.
Moreover, increased spending on research related to genomics and
next-generation sequencing is further contributing to the growing demand for
DNA biochips.
Major
players operating in the global biochip market are Abbott
Laboratories Ltd., Agilent Technologies, Inc., PerkinElmer Inc., Fluidigm
Corporation, Illumina, Inc., GE Healthcare Inc., Bio-Rad Laboratories Inc.,
Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, bioMérieux SA, Horiba,
Ltd., Qiagen N.V., Randox Laboratories Ltd., OriGene Technologies, Inc.,
Hologic, Inc., among others. Companies are
investing in developing advanced technologies and launching new services in
order to enhance their product portfolio and are also undergoing inorganic
growth strategies such as mergers & acquisitions, strategic partnerships,
collaborations and joint ventures.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=1259
Customers can also request for 10% free customization on this report.
“Regionally, North America is expected to dominate the global
biochip market through 2026 on account of growing prevalence of various sedentary
lifestyle associated diseases in the countries like United States and Canada.
However, the Asia Pacific region is expected to register the fastest CAGR
during the forecast period owing to the growth in life science industry and
improving healthcare facilities in the region. Additionally, major players operating in the market
are expanding their business in the region especially in countries like India
and China, positively influencing the growth of the market.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“Global Biochip Market By
Technology (Microarray v/s Microfluidics), By Type (DNA Chips, Lab-On-a-Chips,
Protein Chips, Others), By Application (Drug Discovery & Development,
Disease Diagnostics, Genomics, Proteomics, Others), By End User (Biotechnology
& Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic
& Research Institutes, Others), By Company, By Region, Forecast &
Opportunities, 2026” has evaluated the future growth potential of biochip market
and provides statistics and information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in the global biochip market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/